SHCR - SHCR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Sharecare to Boston Scientific | Benzinga
MONSEY, New York, June 24, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $1.43 per share in cash for which Sharecare, Inc. (NASDAQ:SHCR) ("Sharecare") has agreed to be sold to Altaris, an investment firm exclusively focused on the healthcare industry. The sales price is below the price target for Sharecare of at least one Wall Street analyst (source: TipRanks).
If you remain a Sharecare shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge: